Business description: Sinopharm Group Co. Ltd.

Sinopharm Group Co Ltd is a China-based company principally engaged in pharmaceutical and medical devices distribution business.The Company operates its business through four segments. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services to domestic and foreign pharmaceutical and health product manufacturers and other suppliers. The Device Distribution segment distributes medical devices to customers. The Pharmaceutical Retail Business segment owns a network of retail pharmacies that are directly operated or franchised. The Other Business segment is engaged in the manufacture and sale of pharmaceuticals, chemical reagents and laboratory supplies.

Number of employees: 108,217

Sales by Activity: Sinopharm Group Co. Ltd.

Fiscal Period: December20202021202220232024

Pharmaceutical Distribution

348B 390B 407B 441B 444B

Medical Devices

89.4B 108B 121B 130B 118B

Retail Pharmacy

24.16B 29.06B 32.98B 35.69B 35.98B

Other Business

7.65B 9.82B 10.21B 10.39B 9.11B

Eliminations

-13.1B -15.91B -18.5B -20.77B -22.86B
See all business segments

Geographical breakdown of sales: Sinopharm Group Co. Ltd.

Fiscal Period: December20202021202220232024

People's Republic of China (PRC)

456B 521B 552B 597B 585B
See all geographic segments

Executive Committee: Sinopharm Group Co. Ltd.

Manager TitleAgeSince
President 55 2024-08-26
Corporate Secretary 55 -
Director of Finance/CFO 61 2010-04-30
Corporate Officer/Principal 56 2011-02-28
Corporate Officer/Principal 60 2010-04-30
See SINOPHARM GROUP CO. LTD. governance

Composition of the Board of Directors: Sinopharm Group Co. Ltd.

Director TitleAgeSince
Director/Board Member 53 2010-04-30
Director/Board Member 55 2014-09-20
Director/Board Member 53 2017-08-31
Chairman 54 -
Director/Board Member 48 2020-06-10
Director/Board Member 59 2020-09-17
Director/Board Member 62 2020-09-17
Director/Board Member 51 2020-09-17
Director/Board Member 62 2020-09-17
Director/Board Member 56 2023-06-14
Composition of the Board of Directors

Shareholders: Sinopharm Group Co. Ltd.

NameEquities%Valuation
Lazard Asset Management LLC
9.058 %
121,547,064 9.058 % 285 M $
Fidelity Management & Research Co. LLC
5.299 %
71,104,795 5.299 % 166 M $
FIAM LLC
2.785 %
37,368,882 2.785 % 87 M $
BlackRock Fund Advisors
1.593 %
21,376,400 1.593 % 50 M $
JPMorgan Asset Management (Asia Pacific) Ltd.
1.584 %
21,247,600 1.584 % 50 M $
NameEquities%Valuation
RhumbLine Advisers LP
0.00041 %
1,101 0.00041 % 12 889 $
GAMMA Investing LLC
0.000076 %
205 0.000076 % 2 400 $
PNC Investments LLC
0.000046 %
123 0.000046 % 1 440 $
NameEquities%Valuation
Sinopharm Industrial Investment Co., Ltd.
88.35 %
1,571,555,953 88.35 % 3 680 M $
China State-Owned Assets Supervision & Admn Commission
11.65 %
207,289,498 11.65 % 485 M $
List of SINOPHARM GROUP CO. LTD. shareholders

Company details: Sinopharm Group Co. Ltd.

Sinopharm Group Co., Ltd.

Sinopharm Group Building No. 385, East Longhua Road

200023, Shanghai

+86 21 2305 2666

http://ir.sinopharmgroup.com.cn
address Sinopharm Group Co. Ltd.(1099)

Pharmaceuticals Wholesale

Change 5d. change 1-year change 3-years change Capi.($)
+0.64%+1.73%-4.85%-4.37% 7.44B
-0.69%-1.35%+23.36%+115.81% 89.39B
-0.74%-2.40%+70.41%+203.77% 38.71B
+0.35%-4.98% - - 21.59B
+0.73%-1.57%+47.10%-10.62% 9.72B
+1.60%+5.97%+0.32%+2.76% 8.71B
-0.68%-1.24%+15.56%+14.13% 5.52B
+0.93%-1.80%-14.32%-5.59% 5.21B
-0.50%+1.72%+20.12%+3.69% 4.93B
+0.38%+2.69%+12.66%+20.35% 3.7B
Average +0.26%+0.67%+18.93%+37.77% 19.49B
Weighted average by Cap. -0.00%-0.52%+31.13%+105.41%
See all sector performances
Trading Rating
Investor Rating
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
17.20CNY
Average target price
20.35CNY
Spread / Average Target
+18.28%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 1099 Stock
  4. Company Sinopharm Group Co. Ltd.